Copyright 2024 The Science Publishers
All Rights Reserved for Website Design.
ISSN 2410-955X - An International Biannual Journal
Long non-coding RNA RP5-821D11.7 promotes proliferation, migration, and epithelial-mesenchymal transition in glioma and glioma stem-like cells
Muhammad Younis 1, Sana Shaikh 2, Khawar Ali Shahzad* 3
1 Center for Inflammation, Immunity & Infection, Georgia State University, Institute for Biomedical Sciences, Atlanta, GA, USA
2 Department of Biochemistry and Molecular Biology, Medical School of Southeast University, Nanjing, China
3 Department of Zoology, the Islamia University of Bahawalpur, Bahawalpur, Pakistan
Abstract
Long noncoding RNA (lncRNA) has been recently revealed as a main regulatory molecule, implicating many cellular functions. Studies showed that lncRNA is abnormally expressed and involved in the progression and tumorigenesis of glioma. The present study identified a novel lncRNA associated with glioma, glioma stem-like cells (GSCs) and then revealed their potential functions. During the screening of lncRNAs, we found lncRNA RP5-821D11.7 (lncRNA-RP5) overexpress in GSCs compared to glioma cells. Lentivirus-mediated shRNA for lncRNA-RP5 was constructed and transfected into glioma cells. Transfected stable glioma cells were transplanted into nude mice and tumor growth was determined. Knockdown of lncRNA-RP5 significantly inhibits proliferation, migration and reduces epithelial-mesenchymal transition (EMT) by activating the Wnt/?-catenin pathway. Additionally, the results showed that lncRNA RP5 knockdown enhances cell apoptosis through endoplasmic reticulum stress. Therefore, this study may provide a better understanding and demonstrates that lncRNA-RP5 may be a potential therapeutic target in glioma.
A R T I C L E I N F O
Received
March 12, 2023
Revised
May 17, 2023
Accepted
June 07, 2023
*Corresponding Author
Khawar Ali Shahzad
E-mail
khawar7bar@yahoo.com
m_younisbioc@yahoo.com
Keywords
LncRNA
Apoptosis
ER stress
Epithelial-mesenchymal transition
glioma stem-like cells
Note
Authors equally contributed
2023 | Volume 9 | Issue 2